Loading organizations...
SwanBio Therapeutics has raised $108.0M across 2 funding rounds.
SwanBio Therapeutics has raised $108.0M in total across 2 funding rounds.
SwanBio Therapeutics has raised $108.0M in total across 2 funding rounds.
SwanBio Therapeutics's investors include Mass General Brigham Ventures, Chris Hollowood, Partners Innovation Fund, Syncona.
SwanBio Therapeutics has raised $108.0M across 2 funding rounds. Most recently, it raised $56.0M Series B in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 18, 2022 | $56M Series B | Mass General Brigham Ventures, Chris Hollowood | — | Announced |
| Apr 24, 2020 | $52M Series A Plus | Partners Innovation Fund, Syncona | — | Announced |
